Evidence map›Paper›PMID 38226759›Full record

ArticleAlcohol, clinical & experimental research2023

Modeling the impact of a long-term horizon and multiple treatment episodes on estimates of the cost-effectiveness of alcohol treatment in the United States.

Carolina Barbosa, William N Dowd, Katherine J Karriker-Jaffe, Gary Zarkin

Abstract read
In one paragraph

Article in Alcohol, clinical & experimental research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carolina BarbosaRTI International, Research Triangle Park, North Carolina, USA.ORCID https://orcid.org/0000-0002-7535-9443
William N DowdRTI International, Research Triangle Park, North Carolina, USA.ORCID https://orcid.org/0000-0002-6331-060X
Katherine J Karriker-JaffeRTI International, Berkeley, California, USA.ORCID https://orcid.org/0000-0002-2019-0222
Gary ZarkinRTI International, Research Triangle Park, North Carolina, USA.

Funding

Supplement for Cloud Computing: Alcohol Use Disorder Treatment SimulationR01AA029812 · NIAAA · RESEARCH TRIANGLE INSTITUTE · PI Katherine J. Karriker-Jaffe · 2022 to 2026
$4.1M
The Long-term Costs and Benefits of Alcohol TreatmentsR01AA024423 · NIAAA · RESEARCH TRIANGLE INSTITUTE · PI BARBOSA, CAROLINA · 2016 to 2018
$692k
NIAAA NIH HHS R01 AA024423NIAAA NIH HHS R01AA024423NIAAA NIH HHS R01 AA029812NIAAA NIH HHS R01AA029812
6 · The paper itself

Abstract

backgroundMost clinical studies of alcohol use disorder (AUD) treatment have short follow-up periods, underestimating the full benefits of alcohol treatment. Furthermore, clinical studies only consider one treatment cycle and do not account for the need for multiple episodes to treat a chronic recurrent condition.

methodsA validated microsimulation model of the long-term drinking patterns of people with AUD in the United States simulated 10,000 individuals resembling those from a large clinical trial. The model was used to assess the impact of (1) 1-year, 5-year, and lifetime horizon on alcohol treatment cost-effectiveness estimates and (2) no, one, two, four, and unlimited additional treatment episodes on alcohol treatment cost-effectiveness estimates. Model outcomes included healthcare costs, crime costs, labor market productivity, life expectancy, quality-adjusted life years (QALYs), alcohol-related hospitalizations, and deaths. Cost-effectiveness analyses were conducted for two perspectives: a healthcare perspective that included costs from hospitalization and AUD treatment, and a broader societal perspective that also included crime costs and productivity.

resultsThe incremental cost per additional QALY gained for alcohol treatment compared with no treatment decreased from $55,590 after 1 year to $78 when healthcare costs and QALYs were tracked over the lifetime, that is, treatment became more cost effective. Treatment was cost saving for any time frame when the impacts on crime and labor productivity were also accounted for in a societal perspective. Access to multiple treatment episodes dominated (i.e., it was more effective and less costly) than no-treatment and one-episode scenarios. From a healthcare perspective, incremental costs per additional QALY for increasing from a maximum of two to four treatment episodes was $499 and from four to unlimited episodes was $5049. The unlimited treatment scenario dominated all others from a societal perspective. Results were robust in sensitivity analyses.

conclusionsA long-term perspective and multiple episodes of alcohol treatment improve cost-effectiveness estimates. When societal impacts are included, alcohol treatment is cost saving. Results support the value of alcohol treatment.

Indexed as

alcohol treatmentalcohol use disordercost-effectiveness analysisdrinking patternssimulation modeling

Identifiers

PMID38226759
PMCPMC10792252

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.